Meghana Rao

Company: Rondo Therapeutics

Job title: Vice President - Business Development

Seminars:

Panel Discussion: Maximizing the Market Opportunity of Multispecific Engagers or Combinatorial Treatment Strategies Involving Engagers to Cement the Role of Engagers in the Global Therapeutic Arsenal 9:20 am

How are engagers bringing something different compared to existing modalities in terms of good efficacy, durability of response, and better safety profiles by creating memory T cells and immune surveillance, as opposed to just huge but short-lived efficacy outcomes? How can engagers be complementary to other drug modalities, such as ADCs, to achieve improved patient…Read more

day: Conference Day Two